Welcome to the future of ENT

References
1. Karanfilov, B. Silvers, S. Pasha, R. (2012). Office-based balloon sinus dilation: a prospective, multicenter study of 203 patients. International Forum of Allergy & Rhinology.
2. Ockermann, T., Reineke, U., Upile, T., et al. (2010). Balloon Dilation Eustachian Tuboplasty: A Clinical Study. The Laryngoscope. 120; 1411-1416.
3. Rosenfeld, R.M., Piccirillo, J.F., Chandrasekhar, S.S., et al. (2015). Clinical Practice Guideline (Update): *** Sinusitis. Otolaryngology – Head and Neck Surgery, 152(2S); S1–S39.
4. Nouraei, S.A.R., Ma, E., Patel, A., Howard, D.J., and Sandhu, G.S. (2007). Estimating the population incidence of *** post-intubation laryngotracheal stenosis. Clinical Otolaryngology, 32, 399–420.
5. https://www.entnet.org/content/about-usACCLARENT AERA® Eustachian Tube Balloon Dilation System is intended for use by physicians who are trained on Acclarent Technology. Eustachian tube balloon dilation has associated risks, including tissue and mucosal trauma, infection, or possible carotid artery injury. 
 
Acclarent devices are intended for use by or under the direction of a physician who is trained in the use of Acclarent Technology. INSPIRA AIR® Balloon Dilation System use has described risks, including serious complicati*** such as airway obstruction, airway rupture (partial or complete) resulting in pneumomediastinum, pneumothorax and mediastinitis, chest pain, bronchospa***, atelectasis, pulmonary edema and bleeding. 
 
Acclarent N***igation Technology is intended for use by or under the direction of a physician. Devices guided by the Acclarent N***igation Technology h***e described risks including the potential for unintended injury to the orbits or CNS as a c***equence of inaccurate n***igation. 

ACCLARENT® Balloon Sinuplasty Devices are intended for use by or under the direction of a physician who is trained in the use of Acclarent Technology. ACCLARENT® Balloon Sinuplasty Device use has described risks, including tissue and mucosal trauma, infection, or possible orbital injury. Prior to use, it is important to read the Instructi*** for Use and to understand the contraindicati***, warnings, and precauti*** associated with these devices, as well as all products mentioned on this resource.

The RELIEVA TRACT™ Nasal Balloon Dilation System is an instrument intended to provide increased intranasal space to facilitate access for endonasal and trans-nasal procedures and/or temporarily address nasal obstruction by displacing the inferior turbinate and lower nasal septum. The RELIEVA TRACT™ Nasal Balloon Dilation System is intended for use in ages 17 years or older. Balloon dilation catheters should be used by or under supervision of physicians thoroughly trained in balloon dilation. A thorough understanding of the technical principles, clinical application, and risk associated with balloon dilation of the nasal passage is necessary before using this device.
 
Prior to use, it is important to read the Instructi*** for Use and to understand the contraindicati***, warnings, and precauti*** associated with these devices. 
 
Caution: Federal (US) law restricts the sale, distribution or use of these devices to, by or on the order of a physician. Third party trademarks used herein are trademarks of their respective owners. This content is intended for audience within the US only. 

This site is intended for Healthcare Professionals. This site is published by Acclarent, Inc., which is solely resp***ible for its contents. It is intended for visitors of the United States.